Recruiting for Phase 1 Clinical Trials During a Full Lockdown, Upcoming Webinar Hosted by Xtalks

Share Article

In this free webinar, the featured speakers will discuss how Nucleus Network pivoted from the familiar transient participant pool to a local population during a severe lockdown and how it was able to leverage the new profile of medical research and clinical trials to generate earned media coverage. Attendees will learn about strategies that were implemented to rapidly retarget to a new audience and gain insight into the motivations of participants during this period.

In this webinar, we will be discussing initiatives implemented in adapting to the “new norm,” as well as the outlook in Australia for healthy volunteer recruitment in a restricted market.

A successful clinical trial requires many things, but perhaps the most resource-intensive element is the timely recruiting of an adequate number of suitable, reliable participants that meet the protocol guidelines. This is even more important when the trial needs to target patients with conditions or specific genetic backgrounds.

With the pandemic reducing the volume of international travelers that had previously formed a large portion of the participant pool, Nucleus Network pivoted to target other demographics to fill the participant cohorts for their clinical trials. Whilst not without its challenges in an unpredictable and unchartered market, Nucleus has proceeded with delivering recruitment volumes at a rate equal to or exceeding the pre-COVID level.

In this webinar, we will be discussing initiatives implemented in adapting to the “new norm,” as well as the outlook in Australia for healthy volunteer recruitment in a restricted market. Register for this webinar to hear about how:

  • Australia is open for business for Phase 1 and scaling up medical research capacity
  • With facilities in the USA and Australia, Nucleus Network can offer integrated, multi-site trial capability
  • Interest in medical research is higher than ever in the general public and harnessing this for clinical trials requires a new approach

Join expert speakers from Nucleus Network, Cameron Johnson, CEO; Jeffrey Wong, Director of Business Development; and Mari Ericksen, Director of Marketing and Communications in a live webinar on Tuesday, February 23, 2021 at 4pm EST.

For more information, or to register for this event, visit Recruiting for Phase 1 Clinical Trials During a Full Lockdown.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sydney Perelmutter
Xtalks
+1 (416) 977-6555 x 352
Email >
Visit website